Labroots invites you to the 4th Annual CRISPR Virtual Event! This event will continue the conversation of the abilities of CRISPR-based editing, next-gen editing tools, precision in gene editing and using CRISPR for drug discovery.
The planning committee will bring together thought leaders from academia, trained researchers from clinical laboratories, and industry experts from pharmaceutical to biotech. Experts will share case studies, experiences, and new developments regarding best practices and address appropriate alternatives that are currently being developed.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2020 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of Labroots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 CRISPR Virtual Event. Submission is free. Submit your abstract here.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRcrispr to follow the conversation!
GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a ...See more See less
Millipore Sigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis ...See more See less
Miltenyi Biotec delivers solutions that advance biomedical research and cellular therapy. As the SARS-CoV-2 pandemic continues to take its toll around the world, Miltenyi Biotec stands committed to helping our customers navigate through this challenging time. With over 30 years ...See more See less
Micro refers to our expertise in microfluidics and GEM stands for Genes, Enzymes, and Microbes. MicroGEM is putting rapid diagnostic capabilities where they're needed most - whether it's a farmer's field in Uganda to diagnose cassava mosaic virus or the depths of the Pacific ...See more See less
ATCC is the premier global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. While ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
10x Genomics, Inc. is building tools for scientific discovery that reveal and address the true complexities of biology and disease. Through a combination of novel microfluidics, chemistry and bioinformatics, our award-winning Chromium System is enabling researchers around the ...See more See less
DNA Script was created to revolutionize DNA write with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM, the world's first ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events
Originally from San Diego, CA, Gray moved to North Carolina for college and graduated from University of North Carolina at Greensboro in 2013 (summa cum laude, 4.0) with a B.S. in Biology (biotechnology concentration) with chemistry and anthropology minors. In 2018, they ...See more See less
Kiana received her PhD in Biomedical Engineering at Rutgers University. She then continued her postdoctoral studies in bio-engineering at the UC Berkeley. She is a recipient of the National Institutes of Health postdoctoral training fellowship at the Buck Institute for Age ...See more See less
Research And Development
Labroots Registration (Also interested in)55%
WAVE Newsletter Promotion1%
Trending Newsletter Promotion1%
Medical Laboratory Technician5%
Clinical Laboratory Scientist4%
Life Science Company2%
Manufacturer & Biotech/pharma1%